Mechanistic Computational Model of Ovarian Steroidogenesis to Predict Biochemical Responses to Endocrine Active Compounds

Sex steroids, which have an important role in a wide range of physiological and pathological processes, are synthesized primarily in the gonads and adrenal glands through a series of enzyme-mediated reactions. The activity of steroidogenic enzymes can be altered by a variety of endocrine active compounds (EAC), some of which are therapeutics and others that are environmental contaminants. A steady-state computational model of the intraovarian metabolic network was developed to predict the synthesis and secretion of testosterone (T) and estradiol (E2), and their responses to EAC. Model predictions were compared to data from an in vitro steroidogenesis assay with ovary explants from a small fish model, the fathead minnow. Model parameters were estimated using an iterative optimization algorithm. Model-predicted concentrations of T and E2 closely correspond to the time–course data from baseline (control) experiments, and dose–response data from experiments with the EAC, fadrozole (FAD). A sensitivity analysis of the model parameters identified specific transport and metabolic processes that most influence the concentrations of T and E2, which included uptake of cholesterol into the ovary, secretion of androstenedione (AD) from the ovary, and conversions of AD to T, and AD to estrone (E1). The sensitivity analysis also indicated the E1 pathway as the preferred pathway for E2 synthesis, as compared to the T pathway. Our study demonstrates the feasibility of using the steroidogenesis model to predict T and E2 concentrations, in vitro, while reducing model complexity with a steady-state assumption. This capability could be useful for pharmaceutical development and environmental health assessments with EAC.

[1]  A. Howell,et al.  Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  H. Budzinski,et al.  Analysis of hormonal steroids in fish plasma and bile by coupling solid-phase extraction to GC/MS , 2006, Analytical and bioanalytical chemistry.

[3]  Martin van den Berg,et al.  Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. , 2002, Toxicology and applied pharmacology.

[4]  R. Santen,et al.  Potency and specificity of CGS-16949A as an aromatase inhibitor. , 1990, Endocrine research.

[5]  J. Schoer,et al.  A potential role for sterol carrier protein-2 in cholesterol transfer to mitochondria. , 2000, Chemistry and physics of lipids.

[6]  R. Santen,et al.  Use of aromatase inhibitors in breast carcinoma. , 1999, Endocrine-related cancer.

[7]  M. Lang,et al.  Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  D. Stocco,et al.  Econazole and miconazole inhibit steroidogenesis and disrupt steroidogenic acute regulatory (StAR) protein expression post-transcriptionally , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  A M Vinggaard,et al.  Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  R. Santen,et al.  The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  R. Auchus,et al.  Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. , 2005, Endocrinology.

[12]  G. Ankley,et al.  Description and evaluation of a short‐term reproduction test with the fathead minnow (Pimephales promelas) , 2001, Environmental toxicology and chemistry.

[13]  J. Simard,et al.  Characterization of the guinea pig 3β-hydroxysteroid dehydrogenase/Δ5–Δ4-isomerase expressed in the adrenal gland and gonads , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Daniel L Villeneuve,et al.  Relationship between brain and ovary aromatase activity and isoform-specific aromatase mRNA expression in the fathead minnow (Pimephales promelas). , 2006, Aquatic toxicology.

[15]  Leslie J. Browne,et al.  In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A , 1987, Steroids.

[16]  Cheryl A Murphy,et al.  Modeling vitellogenesis in female fish exposed to environmental stressors: predicting the effects of endocrine disturbance due to exposure to a PCB mixture and cadmium. , 2005, Reproductive toxicology.

[17]  F. Maxfield,et al.  Intracellular cholesterol transport , 2002, The Journal of clinical investigation.

[18]  M. van den Berg,et al.  Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. , 2001, Environmental health perspectives.

[19]  Gerald T Ankley,et al.  Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  W. Miller,et al.  Minireview: regulation of steroidogenesis by electron transfer. , 2005, Endocrinology.

[21]  J. Narbonne,et al.  Induction and inhibition of rat liver cytochrome(s) P-450 by an imidazole fungicide (prochloraz). , 1989, Toxicology.

[22]  Eberhard O. Voit,et al.  Computational Analysis of Biochemical Systems: A Practical Guide for Biochemists and Molecular Biologists , 2000 .

[23]  G. Ankley,et al.  Aspects of basic reproductive biology and endocrinology in the fathead minnow (Pimephales promelas). , 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[24]  A. Matter,et al.  CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. , 1988, Cancer research.

[25]  Virginie Nahoum,et al.  How estrogen‐specific proteins discriminate estrogens from androgens: A common steroid‐binding site architecture , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  W. Yue,et al.  Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[28]  R. Conolly,et al.  Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  H. Burger Androgen production in women. , 2002, Fertility and sterility.

[30]  D. B. Hales,et al.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. , 2004, Endocrine reviews.

[31]  W. Miller,et al.  Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StARProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  W L Miller,et al.  Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.

[33]  L. Ewing,et al.  Mathematical model of steroidogenesis in rat and rabbit testes. , 1980, The American journal of physiology.

[34]  Y. Yamauchi,et al.  Cholesterol sensing, trafficking, and esterification. , 2006, Annual review of cell and developmental biology.

[35]  Daniel L Villeneuve,et al.  Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. , 2007, Ecotoxicology and environmental safety.

[36]  J. Garber,et al.  Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor. , 1991, The Journal of clinical endocrinology and metabolism.

[37]  Daniel L Villeneuve,et al.  Ketoconazole in the fathead minnow (Pimephales promelas): Reproductive toxicity and biological compensation , 2007, Environmental toxicology and chemistry.

[38]  G. Callard,et al.  Different catalytic properties and inhibitor responses of the goldfish brain and ovary aromatase isozymes. , 2001, General and comparative endocrinology.

[39]  J. Pitha,et al.  Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin* , 1996, The Journal of Biological Chemistry.

[40]  Kelly R. Munkittrick,et al.  PROTOCOL FOR MEASURING IN VITRO STEROID PRODUCTION BY FISH GONADAL TISSUE , 1995 .

[41]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[42]  D. Stocco,et al.  Regulation of the acute production of steroids in steroidogenic cells. , 1996, Endocrine reviews.